Authors
Simon Gritsch, MD Kiran Kumar Bali, PhD Rohini Kuner, Ph Daniel Vardeh, MD
Lab
Institute for Pharmacology, University of Heidelberg, Heidelberg, Germany
Journal
Mol Pain
Abstract
Stroke patients often suffer from a central neuropathic pain syndrome called central post-stroke pain. This syndrome is characterized by evoked pain hypersensitivity as well as spontaneous, on-going pain in the body area affected by the stroke. Clinical evidence strongly suggests a dysfunction in central pain pathways as an important pathophysiological factor in the development of central post-stroke pain, but the exact underlying mechanisms remain poorly understood. To elucidate the underlying pathophysiology of central post-stroke pain, we generated a mouse model that is based on a unilateral stereotactic lesion of the thalamic ventral posterolateral nucleus, which typically causes central post-stroke pain in humans.
BIOSEB Instruments Used:
Cold Hot Plate Test (BIO-CHP)